Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 113
Filter
1.
Nutrients ; 14(12)2022 Jun 17.
Article in English | MEDLINE | ID: mdl-35745255

ABSTRACT

The trace element zinc (Zn) binds to over ten percent of proteins in eukaryotic cells. Zn flexible chemistry allows it to regulate the activity of hundreds of enzymes and influence scores of metabolic processes in cells throughout the body. Deficiency of Zn in humans has a profound effect on development and in adults later in life, particularly in the brain, where Zn deficiency is linked to several neurological disorders. In this review, we will summarize the importance of Zn during development through a description of the outcomes of both genetic and early dietary Zn deficiency, focusing on the pathological consequences on the whole body and brain. The epidemiology and the symptomology of Zn deficiency in humans will be described, including the most studied inherited Zn deficiency disease, Acrodermatitis enteropathica. In addition, we will give an overview of the different forms and animal models of Zn deficiency, as well as the 24 Zn transporters, distributed into two families: the ZIPs and the ZnTs, which control the balance of Zn throughout the body. Lastly, we will describe the TRPM7 ion channel, which was recently shown to contribute to intestinal Zn absorption and has its own significant impact on early embryonic development.


Subject(s)
Acrodermatitis , Cation Transport Proteins , Acrodermatitis/metabolism , Animals , Brain/metabolism , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Female , Pregnancy , Zinc/deficiency
2.
Biomolecules ; 12(5)2022 05 21.
Article in English | MEDLINE | ID: mdl-35625653

ABSTRACT

The human (h) transporter hZIP4 is the primary Zn2+ importer in the intestine. hZIP4 is also expressed in a variety of organs such as the pancreas and brain. Dysfunction of hZIP4 can result in the Zn2+ deficiency disease acrodermatitis enteropathica (AE). AE can disrupt digestive and immune system homeostasis. A limited number of hZIP4 expression strategies have hindered increasing knowledge about this essential transmembrane protein. Here, we report the heterologous expression of hZIP4 in Saccharomyces cerevisiae. Both a wild-type and a mutant S. cerevisiae strain, in which the endogenous Zn2+ transporters were deleted, were used to test the expression and localization of an hZIP4-GFP fusion protein. A full-length hZIP4-GFP and a truncated membrane-domain-only (mhZIP4-GFP) protein were observed to be present in the plasma membrane in yeast.


Subject(s)
Acrodermatitis , Cation Transport Proteins , Acrodermatitis/metabolism , Carrier Proteins , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Humans , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Zinc/deficiency
3.
Int J Mol Sci ; 21(3)2020 Jan 22.
Article in English | MEDLINE | ID: mdl-31979155

ABSTRACT

Cellular Zn2+ homeostasis is tightly regulated and primarily mediated by designated Zn2+ transport proteins, namely zinc transporters (ZnTs; SLC30) that shuttle Zn2+ efflux, and ZRT-IRT-like proteins (ZIPs; SLC39) that mediate Zn2+ influx. While the functional determinants of ZnT-mediated Zn2+ efflux are elucidated, those of ZIP transporters are lesser understood. Previous work has suggested three distinct molecular mechanisms: (I) HCO3- or (II) H+ coupled Zn2+ transport, or (III) a pH regulated electrodiffusional mode of transport. Here, using live-cell fluorescent imaging of Zn2+ and H+, in cells expressing ZIP4, we set out to interrogate its function. Intracellular pH changes or the presence of HCO3- failed to induce Zn2+ influx. In contrast, extracellular acidification stimulated ZIP4 dependent Zn2+ uptake. Furthermore, Zn2+ uptake was coupled to enhanced H+ influx in cells expressing ZIP4, thus indicating that ZIP4 is not acting as a pH regulated channel but rather as an H+ powered Zn2+ co-transporter. We further illustrate how this functional mechanism is affected by genetic variants in SLC39A4 that in turn lead to Acrodermatitis enteropathica, a rare condition of Zn2+ deficiency.


Subject(s)
Acrodermatitis/metabolism , Carrier Proteins/metabolism , Cation Transport Proteins/metabolism , Zinc/deficiency , Zinc/metabolism , Biological Transport/physiology , Cell Line , HEK293 Cells , Homeostasis/physiology , Humans , Hydrogen-Ion Concentration , Protons
4.
Biochem J ; 476(12): 1791-1803, 2019 06 28.
Article in English | MEDLINE | ID: mdl-31164399

ABSTRACT

The Zrt-/Irt-like protein (ZIP) family mediates zinc influx from extracellular space or intracellular vesicles/organelles, playing a central role in systemic and cellular zinc homeostasis. Out of the 14 family members encoded in human genome, ZIP4 is exclusively responsible for zinc uptake from dietary food and dysfunctional mutations of ZIP4 cause a life-threatening genetic disorder, Acrodermatitis Enteropathica (AE). About half of the missense AE-causing mutations occur within the large N-terminal extracellular domain (ECD), and our previous study has shown that ZIP4-ECD is crucial for optimal zinc uptake but the underlying mechanism has not been clarified. In this work, we examined zinc binding to the isolated ZIP4-ECD from Pteropus Alecto (black fruit bat) and located zinc-binding sites with a low micromolar affinity within a histidine-rich loop ubiquitously present in ZIP4 proteins. Zinc binding to this protease-susceptible loop induces a small and highly localized structural perturbation. Mutagenesis and functional study on human ZIP4 by using an improved cell-based zinc uptake assay indicated that the histidine residues within this loop are not involved in preselection of metal substrate but play a role in promoting zinc transport. The possible function of the histidine-rich loop as a metal chaperone facilitating zinc binding to the transport site and/or a zinc sensor allosterically regulating the transport machinery was discussed. This work helps to establish the structure/function relationship of ZIP4 and also sheds light on other metal transporters and metalloproteins with clustered histidine residues.


Subject(s)
Acrodermatitis/metabolism , Cation Transport Proteins/metabolism , Mutation, Missense , Zinc/deficiency , Zinc/metabolism , Acrodermatitis/genetics , Acrodermatitis/pathology , Amino Acid Substitution , Biological Transport, Active , Cation Transport Proteins/chemistry , Cation Transport Proteins/genetics , HEK293 Cells , Humans , Protein Structure, Secondary , Structure-Activity Relationship , Zinc/chemistry
5.
Nutrients ; 11(1)2019 Jan 21.
Article in English | MEDLINE | ID: mdl-30669644

ABSTRACT

Acrodermatitis enteropathica (AE) is a rare disease characterised by a failure in intestinal zinc absorption, which results in a host of symptoms that can ultimately lead to death if left untreated. Current clinical treatment involves life-long high-dose zinc supplements, which can introduce complications for overall nutrient balance in the body. Previous studies have therefore explored the pharmacological treatment of AE utilising metal ionophore/transport compounds in an animal model of the disease (conditional knockout (KO) of the zinc transporter, Zip4), with the perspective of finding an alternative to zinc supplementation. In this study we have assessed the utility of a different class of zinc ionophore compound (zinc diethyl bis(N4-methylthiosemicarbazone), Zn-DTSM; Collaborative Medicinal Development, Sausalito, CA, USA) to the one we have previously described (clioquinol), to determine whether it is effective at preventing the stereotypical weight loss present in the animal model of disease. We first utilised an in vitro assay to assess the ionophore capacity of the compound, and then assessed the effect of the compound in three in vivo animal studies (in 1.5-month-old mice at 30 mg/kg/day, and in 5-month old mice at 3 mg/kg/day and 30 mg/kg/day). Our data demonstrate that Zn-DTSM has a pronounced effect on preventing weight loss when administered daily at 30 mg/kg/day; this was apparent in the absence of any added exogenous zinc. This compound had little overall effect on zinc content in various tissues that were assessed, although further characterisation is required to more fully explore the cellular changes underlying the physiological benefit of this compound. These data suggest that Zn-DTSM, or similar compounds, should be further explored as potential therapeutic options for the long-term treatment of AE.


Subject(s)
Acrodermatitis/drug therapy , Cation Transport Proteins/therapeutic use , Intestinal Absorption/drug effects , Ionophores/therapeutic use , Thiosemicarbazones/therapeutic use , Zinc Compounds/therapeutic use , Zinc/deficiency , Acrodermatitis/metabolism , Acrodermatitis/pathology , Animals , Biological Transport , Cation Transport Proteins/metabolism , Dietary Supplements , Disease Models, Animal , Female , Ionophores/metabolism , Male , Mice , Organometallic Compounds/metabolism , Organometallic Compounds/therapeutic use , Thiosemicarbazones/metabolism , Weight Loss/drug effects , Zinc/metabolism , Zinc/therapeutic use , Zinc Compounds/metabolism
6.
BMJ Case Rep ; 20172017 Aug 02.
Article in English | MEDLINE | ID: mdl-28768674

ABSTRACT

Acrodermatitis enteropathica (AE) is a rare inherited zinc deficiency that usually manifests in infancy within days in cases of bottlefed infants and days to weeks after weaning in breastfed infants. It is characterised by diarrhoea, dermatitis, alopecia and systemic symptoms. We report a case of acquired nutritional AE in a 6-month-old female infant who had diarrhoeal episodes and the characteristic dermatitis lesions in the acral and anogenital regions. She responded dramatically to oral zinc supplementation.


Subject(s)
Acrodermatitis/diagnosis , Zinc/deficiency , Zinc/metabolism , Zinc/therapeutic use , Acrodermatitis/metabolism , Administration, Oral , Breast Feeding , Diarrhea/etiology , Female , Humans , Infant , Milk, Human/chemistry , Poverty
7.
Biometals ; 30(5): 643-661, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28717982

ABSTRACT

Zn is essential for growth and development. The bioavailability of Zn is affected by several factors such as other food components. It is therefore of interest, to understand uptake mechanisms of Zn delivering compounds to identify ways to bypass the inhibitory effects of these factors. Here, we studied the effect of Zn amino acid conjugates (ZnAAs) on the bioavailabilty of Zn. We used Caco-2 cells and enterocytes differentiated from human induced pluripotent stem cells from a control and Acrodermatitis enteropathica (AE) patient, and performed fluorescence based assays, protein biochemistry and atomic absorption spectrometry to characterize cellular uptake and absorption of ZnAAs. The results show that ZnAAs are taken up by AA transporters, leading to an intracellular enrichment of Zn mostly uninhibited by Zn uptake antagonists. Enterocytes from AE patients were unable to gain significant Zn through exposure to ZnCl2 but did not show differences with respect to ZnAAs. We conclude that ZnAAs may possess an advantage over classical Zn supplements such as Zn salts, as they may be able to increase bioavailability of Zn, and may be more efficient in patients with AE.


Subject(s)
Acrodermatitis/drug therapy , Amino Acids/pharmacokinetics , Coordination Complexes/pharmacokinetics , Enterocytes/drug effects , Zinc/deficiency , Zinc/pharmacokinetics , Acrodermatitis/metabolism , Acrodermatitis/pathology , Amino Acids/chemistry , Amino Acids/metabolism , Animals , Biological Availability , Biological Transport , Caco-2 Cells , Carrier Proteins/metabolism , Cell Differentiation , Coordination Complexes/chemistry , Coordination Complexes/metabolism , Enterocytes/cytology , Enterocytes/metabolism , Female , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/metabolism , Mice , Mice, Inbred C57BL , Primary Cell Culture , Zinc/chemistry , Zinc/metabolism
8.
J Invest Dermatol ; 137(4): 874-883, 2017 04.
Article in English | MEDLINE | ID: mdl-27940220

ABSTRACT

Acrodermatitis enteropathica is an autosomal recessive disorder characterized by scaly eczematous dermatosis accompanied by alopecia and diarrhea. Various mutations in the SLC39A4 gene (ZIP4), which encodes a zinc transporter, are responsible for this disorder. However, the molecular mechanism underlying the involvement of ZIP4 in the pathogenesis of this condition has yet to be established. In this study, we report the role of ZIP4 in human epidermis. ZIP4 is predominantly expressed in human keratinocytes, and its expression is dramatically reduced on epidermal differentiation. ZIP4 knockdown in human keratinocytes down-regulates zinc (Zn) levels and the transcriptional activity of a key epidermal Zn-binding protein, ΔNp63, and dysregulates epidermal differentiation in a reconstituted human skin model, resulting in the appearance of proliferating keratinocytes even in the uppermost layers of the skin. We verified that, among the amino acid residues in its Zn-binding motif, Cys205 is critical for the processing and nuclear distribution of ΔNp63 and, therefore, Zn-dependent transcriptional activity. Our results suggest that ZIP4 is essential for maintaining human epidermal homeostasis through the regulation of Zn-dependent ΔNp63 activity and can provide insight into the molecular mechanisms responsible for the cutaneous symptoms observed in Acrodermatitis enteropathica patients.


Subject(s)
Acrodermatitis/genetics , Cation Transport Proteins/genetics , Cell Differentiation/genetics , Gene Expression Regulation/genetics , RNA, Small Interfering/metabolism , Zinc/deficiency , Acrodermatitis/metabolism , Adult , Aged , Blotting, Western , Carrier Proteins/genetics , Cells, Cultured , Epidermis/metabolism , Female , Homeostasis/genetics , Humans , Keratinocytes/cytology , Keratinocytes/metabolism , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Reference Values , Sampling Studies , Young Adult , Zinc/metabolism
9.
Nihon Rinsho ; 74(7): 1144-9, 2016 Jul.
Article in Japanese | MEDLINE | ID: mdl-27455804

ABSTRACT

Abstract Acrodermatitis enteropathica(AE) is caused by inherited or acquired zinc deficiency. Cutaneous clinical manifestations observed in AE include characteristic dermatitis on acral, periorificial and anogenital areas through an unknown mechanism. Recently, we found that mice fed a zinc-deficient diet develop a severe irritant contact dermatitis that has the histological features of the skin inflammation seen in AE patients. This finding highlights the possibility that the acral, periorificial and anogenital dermatitis in AE might be caused by contact with different irritants in daily life, such as chemicals, foods, urine or feces, respectively. This review focuses on the recent advances regarding the functional role of zinc in skin and describes how zinc deficiency causes various cutaneous manifestations.


Subject(s)
Acrodermatitis/drug therapy , Acrodermatitis/metabolism , Zinc/deficiency , Zinc/metabolism , Acrodermatitis/pathology , Animals , Apoptosis , Humans , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/pathology , Mucous Membrane/metabolism , Mucous Membrane/pathology
10.
Nihon Rinsho ; 74(7): 1234-8, 2016 Jul.
Article in Japanese | MEDLINE | ID: mdl-27455817

ABSTRACT

Adequate intake of zinc from the daily diet is indispensable to maintain health. However, the dietary zinc content often fails to fulfill the recommended daily intake, leading to zinc deficiency and also increases the risk of developing chronic diseases, particularly in elderly individuals. Therefore, increased attention is required to overcome zinc deficiency and it is important to improve zinc nutrition in daily life. In the small intestine, the zinc transporter, ZIP4, functions as a component that is essential for zinc absorption. In this manuscript, we present a brief overview regarding zinc deficiency. Moreover, we review a novel strategy, called "ZIP4-targeting", which has the potential to enable efficient zinc absorption from the diet. ZIP4-targeting strategy is possibly a major step in preventing zinc deficiency and improving human health.


Subject(s)
Cation Transport Proteins/metabolism , Zinc/metabolism , Acrodermatitis/etiology , Acrodermatitis/metabolism , Animals , Humans , Intestinal Mucosa/metabolism , Nutritional Status , Zinc/deficiency
11.
Arch Biochem Biophys ; 611: 113-119, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27288087

ABSTRACT

Of all tissues, the skin has the third highest abundance of zinc in the body. In the skin, the zinc concentration is higher in the epidermis than in the dermis, owing to a zinc requirement for the active proliferation and differentiation of epidermal keratinocytes. Here we review the dynamics and functions of zinc in the skin as well as skin disorders associated with zinc deficiency, zinc finger domain-containing proteins, and zinc transporters. Among skin disorders associated with zinc deficiency, acrodermatitis enteropathica is a disorder caused by mutations in the ZIP4 transporter and subsequent zinc deficiency. The triad acrodermatitis enteropathica is characterized by alopecia, diarrhea, and skin lesions in acral, periorificial, and anogenital areas. We highlight the underlying mechanism of the development of acrodermatitis because of zinc deficiency by describing our new findings. We also discuss the accumulating evidence on zinc deficiency in alopecia and necrolytic migratory erythema, which is typically associated with glucagonomas.


Subject(s)
Skin Physiological Phenomena , Skin/metabolism , Zinc/physiology , Acrodermatitis/metabolism , Adenosine Triphosphate/chemistry , Alopecia/metabolism , Alopecia Areata/metabolism , Animals , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Cell Differentiation , Cell Proliferation , Dermis/metabolism , Epidermis/metabolism , Glucagonoma/metabolism , Humans , Keratinocytes/cytology , Keratinocytes/metabolism , Langerhans Cells/metabolism , Mutation , Skin Diseases/metabolism , Zinc/deficiency , Zinc/metabolism
12.
Int J Mol Sci ; 17(3): 336, 2016 Mar 04.
Article in English | MEDLINE | ID: mdl-26959009

ABSTRACT

Around 3000 proteins are thought to bind zinc in vivo, which corresponds to ~10% of the human proteome. Zinc plays a pivotal role as a structural, catalytic, and signaling component that functions in numerous physiological processes. It is more widely used as a structural element in proteins than any other transition metal ion, is a catalytic component of many enzymes, and acts as a cellular signaling mediator. Thus, it is expected that zinc metabolism and homeostasis have sophisticated regulation, and elucidating the underlying molecular basis of this is essential to understanding zinc functions in cellular physiology and pathogenesis. In recent decades, an increasing amount of evidence has uncovered critical roles of a number of proteins in zinc metabolism and homeostasis through influxing, chelating, sequestrating, coordinating, releasing, and effluxing zinc. Metallothioneins (MT) and Zrt- and Irt-like proteins (ZIP) and Zn transporters (ZnT) are the proteins primarily involved in these processes, and their malfunction has been implicated in a number of inherited diseases such as acrodermatitis enteropathica. The present review updates our current understanding of the biological functions of MTs and ZIP and ZnT transporters from several new perspectives.


Subject(s)
Cation Transport Proteins/metabolism , Metallothionein/metabolism , Repressor Proteins/metabolism , Zinc/metabolism , Acrodermatitis/metabolism , Animals , Cation Transport Proteins/genetics , Epigenesis, Genetic , Gene Expression Regulation , Genetic Predisposition to Disease , Homeostasis , Humans , Metallothionein/genetics , Phylogeny , Polymorphism, Single Nucleotide , Repressor Proteins/genetics , Zinc/deficiency
13.
Int J Immunopathol Pharmacol ; 29(2): 274-9, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26684640

ABSTRACT

Acrodermatitis enteropathic (AE) is a rare autosomal recessive disorder due to a zinc deficiency and characterized by a classical triad of symptoms: dermatitis, alopecia, and diarrhea. The defective gene is SLC39A4, which encodes a zinc transporter. Nevertheless many abnormalities in SLC39A4 have been relieved, only 50% of patients show alterations. Here is reported the case of an infant with mild and incomplete manifestations of AE, for whom the SLC39A4 genetic test was performed. A novel mutation in SLC39A4 was identified. Zinc replacement improved rapidly the skin lesions. Our case highlights the importance of suspecting this rare condition and to perform the genetic test even in those patients who do not fulfil the classical triad of symptoms. Further efforts should be addressed to identify a more strength correlation between genotype and phenotype of this disorder.


Subject(s)
Acrodermatitis/genetics , Acrodermatitis/pathology , Mutation/genetics , Acrodermatitis/metabolism , Biological Transport/physiology , Cation Transport Proteins/genetics , Genetic Heterogeneity , Humans , Infant , Male , Zinc/metabolism
14.
Nat Commun ; 6: 7287, 2015 Jun 02.
Article in English | MEDLINE | ID: mdl-26031447

ABSTRACT

The vimentin filament network plays a key role in cell architecture and signalling, as well as in epithelial-mesenchymal transition. Vimentin C328 is targeted by various oxidative modifications, but its role in vimentin organization is not known. Here we show that C328 is essential for vimentin network reorganization in response to oxidants and electrophiles, and is required for optimal vimentin performance in network expansion, lysosomal distribution and aggresome formation. C328 may fulfil these roles through interaction with zinc. In vitro, micromolar zinc protects vimentin from iodoacetamide modification and elicits vimentin polymerization into optically detectable structures; in cells, zinc closely associates with vimentin and its depletion causes reversible filament disassembly. Finally, zinc transport-deficient human fibroblasts show increased vimentin solubility and susceptibility to disruption, which are restored by zinc supplementation. These results unveil a critical role of C328 in vimentin organization and open new perspectives for the regulation of intermediate filaments by zinc.


Subject(s)
Acrodermatitis/metabolism , Cysteine/metabolism , Fibroblasts/metabolism , Oxidative Stress , Vimentin/metabolism , Zinc/deficiency , Zinc/metabolism , Acrodermatitis/pathology , Fibroblasts/ultrastructure , Fluorescent Antibody Technique , Humans , Immunoprecipitation , In Vitro Techniques , Microscopy, Confocal , Microscopy, Electron , Optical Imaging , Polymerization , Protein Binding , Proteomics , Vimentin/ultrastructure
15.
PLoS One ; 8(8): e72543, 2013.
Article in English | MEDLINE | ID: mdl-24015258

ABSTRACT

BACKGROUND: Zinc deficiency due to poor nutrition or genetic mutations in zinc transporters is a global health problem and approaches to providing effective dietary zinc supplementation while avoiding potential toxic side effects are needed. METHODS/PRINCIPAL FINDINGS: Conditional knockout of the intestinal zinc transporter Zip4 (Slc39a4) in mice creates a model of the lethal human genetic disease acrodermatitis enteropathica (AE). This knockout leads to acute zinc deficiency resulting in rapid weight loss, disrupted intestine integrity and eventually lethality, and therefore provides a model system in which to examine novel approaches to zinc supplementation. We examined the efficacy of dietary clioquinol (CQ), a well characterized zinc chelator/ionophore, in rescuing the Zip4 (intest KO) phenotype. By 8 days after initiation of the knockout neither dietary CQ nor zinc supplementation in the drinking water was found to be effective at improving this phenotype. In contrast, dietary CQ in conjunction with zinc supplementation was highly effective. Dietary CQ with zinc supplementation rapidly restored intestine stem cell division and differentiation of secretory and the absorptive cells. These changes were accompanied by rapid growth and dramatically increased longevity in the majority of mice, as well as the apparent restoration of the homeostasis of several essential metals in the liver. CONCLUSIONS: These studies suggest that oral CQ (or other 8-hydroxyquinolines) coupled with zinc supplementation could provide a facile approach toward treating zinc deficiency in humans by stimulating stem cell proliferation and differentiation of intestinal epithelial cells.


Subject(s)
Acrodermatitis/drug therapy , Clioquinol/pharmacology , Dietary Supplements , Zinc/deficiency , Zinc/pharmacology , Acrodermatitis/genetics , Acrodermatitis/metabolism , Acrodermatitis/pathology , Animals , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Clioquinol/agonists , Disease Models, Animal , Drug Synergism , Humans , Intestinal Mucosa/metabolism , Intestines/pathology , Liver/metabolism , Liver/pathology , Mice , Mice, Knockout , Zinc/agonists , Zinc/metabolism
16.
Acta Dermatovenerol Croat ; 21(1): 43-7, 2013.
Article in English | MEDLINE | ID: mdl-23683486

ABSTRACT

The Gianotti-Crosti syndrome is a relatively common children dermatosis characterized by a monomorphous erythematous papular rash limited to the face and extensor surface of the arms and legs. Although the pathogenesis is still unclear, infections are considered as the most important factor. Human ß-defensins are cationic antimicrobial peptides closely related to bacterial and viral infections of many epithelia. We herein report a case of Gianotti-Crosti syndrome in a 7-year-old Caucasian girl presented with prominent eruption consisting of dome-shaped lichenoid papules on her upper and lower extremities, with spontaneous resolution. Skin biopsy revealed a dense lichenoid lymphohistiocytic infiltrate and showed strong cytoplasmic immunopositivity for human ß-defensin-4 in the stratum corneum, stratum granulosum, and stratum spinosum. Considering that ß-defensins have been described to be induced by infections, we investigated the expression of human ß-defensin-4 by immunohistochemistry in a case of Gianotti-Crosti syndrome, in order to demonstrate that it represents a cutaneous response to skin infections.


Subject(s)
Acrodermatitis/metabolism , beta-Defensins/metabolism , Acrodermatitis/immunology , Child , Cytoplasm/metabolism , Female , Humans , Immunohistochemistry
18.
Adv Med Sci ; 56(2): 369-72, 2011.
Article in English | MEDLINE | ID: mdl-21983448

ABSTRACT

Acrodermatitis enteropathica is a rare, autosomal recessive condition which results from impaired zinc absorption in the gastrointestinal tract. We report a 16-month-old female patient with a 7-month history of periorificial and acral skin lesions. Diagnosing of Acrodermatitis enteropathica was established on the basis of the patient's history as well as clinical and laboratory findings (a lowered zinc level in the child's serum: 17.2µg/dL (N 70-160 µg/dL)). Rapid clinical improvement was observed right after launching zinc supplementation.


Subject(s)
Acrodermatitis/metabolism , Exanthema/drug therapy , Exanthema/etiology , Skin/drug effects , Zinc/blood , Zinc/deficiency , Absorption , Dietary Supplements , Female , Humans , Infant , Ions , Treatment Outcome , Zinc/metabolism , Zinc Sulfate/administration & dosage
20.
Mol Cell Biol ; 29(1): 129-39, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18936158

ABSTRACT

The zinc transporter ZIP4 (SLC39A4) is mutated in humans with the rare, autosomal recessive genetic disease acrodermatitis enteropathica. In mice, this gene is essential during early embryonic development. ZIP4 is dynamically regulated by multiple posttranscriptional mechanisms, and studies of mouse ZIP4 reported herein reveal that the ectodomain, the extracellular amino-terminal half of the protein, is proteolytically removed during prolonged zinc deficiency while the remaining eight-transmembrane carboxyl-terminal half of the protein is accumulated on the plasma membrane as an abundant form of ZIP4. This novel ZIP4 processing occurs in vivo in the intestine and visceral endoderm, in mouse Hepa cells that express the endogenous Slc39a4 gene and in transfected MDCK and CaCo2 cells, but not HEK293 cells. In transfected MDCK and CaCo2 cells, the ectodomain accumulated and remained associated with membranes when zinc was deficient. ZIP4 cleavage was attenuated by inhibitors of endocytosis, which suggests that the processed protein is recycled back to the plasma membrane and that the ectodomain may be internalized. Ectodomain cleavage is inhibited by acrodermatitis enteropathica mutations near a predicted metalloproteinase cleavage site which is also essential for proper ectodomain cleavage, and overexpression of processed ZIP4 or ZIP4 with ectodomain truncations rendered the mouse Mt1 gene hypersensitive to zinc. These finding suggest that the processing of ZIP4 may represent a significant regulatory mechanism controlling its function.


Subject(s)
Acrodermatitis/genetics , Acrodermatitis/metabolism , Cation Transport Proteins/chemistry , Cation Transport Proteins/metabolism , Mutation/genetics , Protein Processing, Post-Translational , Zinc/deficiency , Amino Acid Motifs , Amino Acid Sequence , Animals , Cell Line , Conserved Sequence , Culture Media , Dogs , Endocytosis , Humans , Mice , Molecular Sequence Data , Protein Structure, Tertiary , Transfection , Yolk Sac/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...